Plasma and brain levels of terpene trilactones in rats after an oral single dose of standardized Ginkgo biloba extract EGb 761®

Planta Medica

Volumn 77, Issue 3, 2011, Pages 259-264

  Ude, Christian ^a   Paulke, Alexander ^a   Nöldner, Michael ^b   Schubert Zsilavecz, Manfred ^a   Wurglics, Mario ^a  

^a GOETHE UNIVERSITY   (Germany)

^b DR WILLMAR SCHWABE GMBH AND CO KG   (Germany)

Author keywords

bilobalide; CNS; Ginkgo biloba; Ginkgoaceae; ginkgolides; terpene trilactones

Indexed keywords

BILOBALIDE; GINKGO BILOBA EXTRACT; GINKGOLIDE A; GINKGOLIDE B; GINKGOLIDE C;

ANIMAL EXPERIMENT; ANIMAL TISSUE; AREA UNDER THE CURVE; ARTICLE; BLOOD BRAIN BARRIER; BRAIN; CENTRAL NERVOUS SYSTEM; DRUG BLOOD LEVEL; DRUG BRAIN LEVEL; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MALE; MAXIMUM PLASMA CONCENTRATION; NONHUMAN; RAT; SINGLE DRUG DOSE; TIME TO MAXIMUM PLASMA CONCENTRATION;

ANIMALS; AREA UNDER CURVE; BLOOD; BLOOD-BRAIN BARRIER; BRAIN; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; GINKGO BILOBA; GINKGOLIDES; LACTONES; MALE; MASS SPECTROMETRY; PLANT EXTRACTS; RATS;

ANIMALIA; GINKGO BILOBA; GINKGOACEAE; RATTUS; RODENTIA;

EID: 79551683865     PISSN: 00320943     EISSN: 14390221     Source Type: Journal    
DOI: 10.1055/s-0030-1250286     Document Type: Article

References (27)

1. Ramassamy C, Longpre F, Christen Y. Ginkgo biloba extract (EGb 761) in Alzheimer's disease: is there any (Pubitemid 47025423)
2. van Beek T A. Chemical analysis of Ginkgo biloba leaves and extracts. J Chromatogr A 2002 967 21-55 (Pubitemid 34786583)
3. IQWiG. IQWiG Abschlussbericht: Ginkgohaltige Präparate bei Alzheimer Demenz. Köln IQWiG 2008
4. Blecharz-Klin K, Piechal A, Joniec I, Pyrzanowska J, Widy-Tyszkiewicz E. Pharmacological and biochemical effects of Ginkgo biloba extract on learning, memory consolidation and motor activity in old rats. Acta Neurobiol Exp (Wars) 2009 69 217-231
5. Abdel-Kader R, Hauptmann S, Keil U, Scherping I, Leuner K, Eckert A, Muller W E. Stabilization of mitochondrial function by Ginkgo biloba extract (EGb 761). Pharmacol Res 2007 56 493-502 (Pubitemid 350148165)
6. Leuner K, Hauptmann S, Abdel-Kader R, Scherping I, Keil U, Strosznajder J B., Eckert A, Muller W E. Mitochondrial dysfunction: the first domino in brain aging and Alzheimer's disease? Antiox Redox Signal 2007 9 1659-1675 (Pubitemid 47462969)
7. Eckert A, Keil U, Scherping I, Hauptmann S, Muller W E. Stabilization of mitochondrial membrane potential and improvement of neuronal energy metabolism by Ginkgo biloba extract EGb 761. Ann N Y Acad Sci 2005 1056 474-485 (Pubitemid 43031000)
8. Kiewert C, Kumar V, Hildmann O, Hartmann J, Hillert M, Klein J. Role of glycine receptors and glycine release for the neuroprotective activity of bilobalide. Brain Res 2008 1201 143-150
9. Fehske C J., Leuner K, Muller W E. Ginkgo biloba extract (EGb761) influences monoaminergic neurotransmission via inhibition of NE uptake, but not MAO activity after chronic treatment. Pharmacol Res 2009 60 68-73
10. Moreau J P., Eck C R., McCabe J, Skinner S. Absorption, distribution and elimination of a labelled extract of Ginkgo biloba leaves in the rat. Presse Med 1986 15 1458-1461 (Pubitemid 16018104)
11. Rangel-Ordóez L, Nöldner M, Schubert-Zsilavecz M, Wurglics M. Plasma levels and distribution of flavonoids in rat brain after single and repeated doses of standardized Ginkgo biloba extract EGb 761®. Planta Med
12. Fourtillan J B., Brisson A M., Girault J, Ingrand I, Decourt J P., Drieu K, Jouenne P, Biber A. Pharmacokinetic properties of bilobalide and ginkgolides A and B in healthy subjects after intravenous and oral administration of Ginkgo biloba extract (EGb 761). Therapie 1995 50 137-144
13. Biber A. Pharmacokinetics of Ginkgo biloba extracts. Pharmacopsychiatry 2003 36 (Suppl. 1) S32-S37 (Pubitemid 37047006)
14. Mauri P, Palma A de, Pozzi F, Basilico F, Riva A, Morazzoni P, Bombardelli E, Rossoni G. LC-MS characterization of terpene lactones in plasma of experimental animals treated with Ginkgo biloba extracts correlation with pharmacological activity. J Pharm Biomed Anal 2006 40 763-768 (Pubitemid 43227401)
15. Xie J, Ding C, Ge Q, Zhou Z, Zhi X. Simultaneous determination of ginkgolides A, B, C and bilobalide in plasma by LC-MS/MS and its application to the pharmacokinetic study of Ginkgo biloba extract in rats. J Chromatogr B Anal Technol Biomed Life Sci 2008 864 87-94
16. Rossi R, Basilico F, Rossoni G, Riva A, Morazzoni P, Mauri P L. Liquid chromatography/atmospheric pressure chemical ionization ion trap mass spectrometry of bilobalide in plasma and brain of rats after oral administration of its phospholipidic complex. J Pharm Biomed Anal 2009 50 224-227
17. Biber A, Koch E. Bioavailability of ginkgolides and bilobalide from extracts of Ginkgo biloba using GC/MS. Planta Med 1999 65 192-193 (Pubitemid 29138164)
18. Ding S, Dudley E, Song Q, Plummer S, Tang J, Newton R P., Brenton A G. Mass spectrometry analysis of terpene lactones in Ginkgo biloba. Rapid Commun Mass Spectrom 2008 22 766-772 (Pubitemid 351442549)
19. Sora D I., Stefanescu V, David V, Medvedovici A. Validation of an LC-MS/MS assay of terpene trilactones in Ginkgo biloba extracts and pharmaceutical formulations through standard addition method. J Pharm Biomed Anal 2009 50 459-468
20. Butterweck V, Liefländer-Wulf U, Winterhoff H, Nahrstedt A. Plasma levels of hypericin in presence of procyanidin B2 and hyperoside: a pharmacokinetic study in rats. Planta Med 2003 69 189-192 (Pubitemid 36470120)
21. Eckert A, Keil U, Kressmann S, Schindowski K, Leutner S, Leutz S, Muller W E. Effects of EGb 761 Ginkgo biloba extract on mitochondrial function and oxidative stress. Pharmacopsychiatry 2003 36 (Suppl. 1) S15-S23 (Pubitemid 37047004)
22. Bate C, Tayebi M, Williams A. Ginkgolides protect against amyloid-beta1-42-mediated synapse damage in vitro. Mol Neurodegener 2008 3 1
23. Kondratskaya E L., Fisyunov A I., Chatterjee S S., Krishtal O A. Ginkgolide B preferentially blocks chloride channels formed by heteromeric glycine receptors in hippocampal pyramidal neurons of rat. Brain Res Bull 2004 63 309-314 (Pubitemid 38758041)
24. Ahlemeyer B, Krieglstein J. Neuroprotective effects of Ginkgo biloba extract. Cell Mol Life Sci 2003 60 1779-1792 (Pubitemid 37222578)
25. Klein J, Chatterjee S S., Loffelholz K. Phospholipid breakdown and choline release under hypoxic conditions: inhibition by bilobalide, a constituent of Ginkgo biloba. Brain Res 1997 755 347-350 (Pubitemid 27196343)
26. Weichel O, Hilgert M, Chatterjee S S., Lehr M, Klein J. Bilobalide, a constituent of Ginkgo biloba, inhibits NMDA-induced phospholipase A2 activation and phospholipid breakdown in rat hippocampus. Naunyn Schmiedebergs Arch Pharmacol 1999 360 609-615 (Pubitemid 30012459)
27. Kiewert C, Kumar V, Hildmann O, Rueda M, Hartmann J, Naik R S., Klein J. Role of GABAergic antagonism in the neuroprotective effects of bilobalide. Brain Res 2007 1128 70-78 (Pubitemid 46048632)